Table 3.
The characteristics of the study population stratified by AST levels.
| Q1 (≤18.4) (N=3538) |
Q2 (18.5-21.7) (N=3528) |
Q3 (21.8-26.6) (N=3548) |
Q4 (≥26.7) (N=3486) |
P | |
|---|---|---|---|---|---|
| Male (%) | 935 (26.43) | 1449 (41.07) | 1826 (51.47) | 2167 (62.16) | <0.001 |
| Age (years) | 38 (32, 51) | 49 (37, 58) | 49 (38, 57) | 42 (34, 53) | <0.001 |
| BMI (kg/m2) * | 22.83±3.05 | 24.59±3.29 | 25.78±3.34 | 27.40±3.85 | <0.001 |
| SBP (mmHg) * | 125.05±16.66 | 129.89±17.88 | 132.40±17.56 | 134.75±17.43 | <0.001 |
| DBP (mmHg)* | 76.36±10.73 | 78.97±11.24 | 80.62±11.62 | 82.34±11.83 | <0.001 |
| Hypertension (%) * | 688 (19.45) | 982 (27.83) | 1212 (34.16) | 1381 (39.62) | <0.001 |
| ALT(IU/L) * | 12.30 (9.90, 15.50) | 17.20 (13.90, 21.40) | 26.20 (18.40, 39.98) | 40.10 (29.48, 56.75) | <0.001 |
| GGT(IU/L) * | 17.00 (13.30, 23.40) | 21.40 (15.80, 30.70) | 26.20 (18.40, 39.98) | 41.10 (26.20, 66.70) | <0.001 |
| FPG (mmol/l) * | 5.08 (4.77, 5.45) | 5.15 (4.82, 5.58) | 5.22 (4.89, 5.64) | 5.32 (4.94, 5.85) | <0.001 |
| HbA1c (%) (n=3017) |
5.60 (5.30, 6.10) | 5.60 (5.40, 6.00) | 5.70 (5.40, 6.00) | 5.70 (5.50, 6.30) | <0.001 |
| TC (mmol/l) * | 4.96±0.94 | 5.21±1.03 | 5.33±1.04 | 5.46±1.09 | <0.001 |
| TG (mmol/l) * | 1.02 (0.75, 1.48) | 1.18 (0.85, 1.69) | 1.38 (0.96, 2.02) | 1.63 (1.11, 2.45) | <0.001 |
| HDL-C (mmol/l) | 1.38±0.29 | 1.39±0.31 | 1.37±0.32 | 1.33±0.31 | <0.001 |
| LDL-C (mmol/l) * | 3.06±0.70 | 3.25±0.74 | 3.33±0.75 | 3.43±0.78 | <0.001 |
| Fatty liver, n (%) | 1082 (30.58) | 1508 (42.74) | 1839 (51.83) | 2362 (67.76) | <0.001 |
| T2D, n (%) | 238 (6.73) | 250 (7.09) | 275 (7.75) | 392 (11.24) | <0.001 |
*: Statistically significant pairwise comparison.